STERIS plc provides infection prevention products and services in the United States Ireland and internationally It operates through three segments Healthcare Applied Sterilization Technologies and Life Sciences The company offers cleaning chemistries and sterility assurance products automated endoscope reprocessing system and tracking products endoscopy accessories instruments washers and sterilizers and other pieces of capital equipment as well as equipment used directly in the procedure rooms including surgical tables lights equipment management services and connectivity solutions and various preventive maintenance programs repair services custom process improvement consulting and outsourced instrument sterile processing as well as instrument devices and endoscope repair and maintenance services It also provides process controls and monitoring systems as well as integrated sterilization equipment such as accelerators product handling and automation and sterilization modalities product development materials testing and process validation as well as support services for sterilization equipment and control systems comprising installation preventive maintenance updates repairs and troubleshooting In addition the company offers pharmaceutical detergents cleanroom disinfectants and sterilants pharmaceutical grade and research sterilizers and washers sterility assurance and maintenance products vaporized hydrogen peroxide room decontamination systems and sterilizers and high purity water and pure steam generators and preventive maintenance programs and repair services to support the operation of capital equipment It serves healthcare providers medical device and pharmaceutical manufacturers biopharmaceutical manufacturing facilities and hospitals The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015 STERIS plc was founded in 1985 and is headquartered in Mentor Ohio
Recent Earnings Surprises
Date
Actual EPS
Estimated EPS
Surprise
2026-05-11
$2.83
$2.85
-0.7%
2026-02-04
$2.53
$2.53
+0.0%
2025-11-05
$2.47
$2.35
+5.1%
2025-08-06
$2.34
$2.26
+3.5%
Financial Ratios (TTM)
Gross Margin
44.25%
Operating Margin
18.56%
Net Margin
13.18%
ROA
7.29%
Price to Book
2.94
Price to Sales
3.54
Valoramos tu privacidad
Usamos cookies para analizar el tráfico y mostrar anuncios. Acepta todas las cookies o continúa solo con las esenciales. Más información